What to Do When Anthem Denies Zepbound: Step-by-Step Appeal
Introduction
Anthem owns 14 Blue Cross Blue Shield licensees and processes pharmacy benefits through CarelonRx (formerly IngenioRx), Anthem’s wholly-owned PBM. Zepbound® denials come back as CarelonRx adverse determinations, and the level-1 appeal goes to CarelonRx first.
Denial reasons cluster around six issues: prior authorization criteria not met, step therapy (often Wegovy® first), BMI below threshold, weight-loss drug carve-out by the employer, OSA criteria missing for the sleep apnea indication, and incomplete documentation of a structured weight management program. Each has a specific counter.
CMS data from 2023 puts the overturn rate at roughly 41 percent for commercial denials when patients file a level-1 internal appeal with new clinical documentation. Zepbound appeals gained an additional lever in 2026 because the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in December 2024 based on SURMOUNT-OSA. That OSA indication is a separate pathway with relaxed criteria on most Anthem plans.
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.
Why Does Anthem Deny Zepbound?
Six denial codes account for roughly 90 percent of Anthem Zepbound rejections. The codes are PA-NOT-MET, NF (non-formulary), STEP-REQ (step therapy required, often Wegovy first), BMI-NOT-MET, EMP-EXCL (employer carve-out), and OSA-DOCS-MISSING (under the OSA indication).
Quick Answer: Anthem processes Zepbound through CarelonRx; level-1 appeals go to CarelonRx first
Pull your CarelonRx adverse determination letter and find the reason code. The wording sits near a phrase reading “reason for adverse determination.” The appeal strategy depends on which code applies.
Anthem’s Zepbound step therapy typically requires prior trial of Wegovy or an older agent before Zepbound. This creates a problem if Wegovy didn’t work. The workaround is a documented prior Wegovy trial showing insufficient response or GI intolerability, which waives the step requirement.
What Is Anthem’s 2026 Prior Authorization for Zepbound?
Anthem’s 2026 commercial PA for Zepbound requires five things: BMI of 30 or higher, or BMI 27 to 29.9 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, OSA, CVD), documentation of a structured weight management program for at least 6 months in the past 24 months, prescriber attestation that lifestyle changes alone have been inadequate, age 18 or older, and concurrent reduced-calorie diet and physical activity.
Most Anthem plans require step therapy with Wegovy or an older weight-loss agent before approving Zepbound. The step requirement can be waived with documented contraindication, intolerance, or insufficient response.
For the OSA indication after SURMOUNT-OSA, Anthem’s PA requires confirmed AHI of 15 or higher on polysomnography and BMI of 30 or higher. The 6-month lifestyle program requirement is typically waived under the OSA pathway, as is the step therapy requirement.
How Do I File a Level-1 Internal Appeal for Zepbound?
You have 180 days from the denial date to file a level-1 internal appeal. The submission goes to CarelonRx Pharmacy Appeals at the address on the denial letter.
The appeal packet should include a signed appeal letter from you, a Letter of Medical Necessity signed by your prescriber, chart notes from the past 12 months, BMI and weight history, documentation of the 6-month weight management program, and prior medication trials with dates and outcomes. If you’re applying under the OSA indication, include the polysomnography report with AHI data.
CarelonRx has 30 days to respond on a standard appeal and 72 hours on an expedited appeal. Expedited appeals require prescriber attestation that delay would seriously jeopardize health.
What Should the Letter of Medical Necessity Say?
The LMN is the single most important document. It should be on prescriber letterhead, signed and dated, and limited to two pages. CarelonRx reviewers spend about 6 minutes per file on average.
Hit five points. First, current BMI and weight, plus BMI trend over 24 months. Second, every comorbidity that meets Anthem criteria with ICD-10 codes. Third, prior weight-loss interventions with dates and outcomes, including any prior Wegovy trial (document GI intolerability or insufficient response with specifics). Fourth, clinical rationale citing SURMOUNT-1 (Jastreboff et al. 2022, NEJM) showing 20.9 percent weight loss at 72 weeks, SURMOUNT-2 (Garvey et al. 2023, Lancet) for patients with type 2 diabetes, and SURMOUNT-OSA for the sleep apnea indication if applicable. Fifth, a statement that lifestyle modifications alone have not produced sustained clinical response.
A focused two-page LMN beats a five-page one almost every time.
What Clinical Evidence Does Anthem Respect?
CarelonRx and Anthem’s P&T committee reference specific trials when updating coverage policy. Citing those trials by name puts your appeal in their internal vocabulary.
For Zepbound in 2026, the strongest references are SURMOUNT-1 (Jastreboff et al. 2022, NEJM) showing 20.9 percent weight loss at 72 weeks, SURMOUNT-2 (Garvey et al. 2023, Lancet) showing 15.7 percent weight loss in patients with type 2 diabetes, SURMOUNT-3 (Wadden et al. 2023, Nature Medicine), SURMOUNT-4 for weight maintenance, and SURMOUNT-OSA for the sleep apnea indication.
Pick the two trials most relevant to your clinical situation. A focused appeal looks more credible than a literature dump.
Key Takeaway: 2026 Anthem PA requires BMI of 30 or higher, or 27 with comorbidity, plus a 6-month documented weight management program
What If the First Appeal Is Denied?
You can file a level-2 internal appeal within 60 days of the level-1 denial, and pursue external review through your state commissioner in parallel.
The level-2 internal appeal at Anthem goes to a different reviewer, usually a board-certified physician. The packet can include the same documents plus a peer-to-peer review request, where your prescriber speaks directly with Anthem’s medical director. Peer-to-peer reviews are typically granted and significantly improve overturn rates.
External review through your state insurance commissioner is independent and decisions are binding. The deadline is usually 4 months from the final internal denial. The IRO assigns a board-certified physician in endocrinology, obesity medicine, or pulmonology (for OSA cases). The review costs nothing. Approval rates run around 50 percent for prescription drug denials.
How Does the OSA Indication Change the Appeal?
If you have moderate-to-severe obstructive sleep apnea with documented AHI of 15 or higher on polysomnography, the OSA indication is a separate appeal pathway with different criteria.
The FDA approved Zepbound for OSA in December 2024 after SURMOUNT-OSA. The trial reduced AHI by about 27 events per hour in the treatment arm versus about 4 in placebo, and 43 percent of treatment-arm patients reached AHI of 5 or fewer events per hour.
The LMN should explicitly state “requested for moderate-to-severe OSA per FDA-approved indication based on SURMOUNT-OSA.” Cite the polysomnography results. Most Anthem plans waive the 6-month lifestyle program and step therapy requirements under the OSA pathway.
What If My Anthem Plan Carves Out Weight-loss Drugs?
This is the hardest denial to overturn because the benefit comes from the employer, not Anthem’s medical policy. You have three practical options.
First, ask HR whether the carve-out applies to all indications or only the obesity indication. The OSA indication may be covered separately on self-funded plans because it is a respiratory disease benefit, not a weight-loss benefit. Second, request a formulary exception based on medical necessity with documented OSA, type 2 diabetes, or CVD. Third, consider cash-pay options. The Eli Lilly LillyDirect cash pharmacy offers Zepbound single-dose vials at $349 to $499 per month, available to commercially-insured patients without coverage and to cash-pay patients.
Compounded tirzepatide is no longer available through 503A pharmacies after the FDA resolved the tirzepatide shortage in late 2024. Compounded semaglutide remains a legal option through licensed telehealth providers like TrimRx, with a free assessment quiz determining eligibility.
How Long Does the Full Appeal Process Take?
A standard level-1 internal appeal takes 30 days. A level-2 takes another 30 days. External review is usually 45 days but can be expedited to 72 hours with documented urgent medical need.
Full timeline through every level: roughly 4 to 5 months from initial denial to a final external review decision. Expedited appeals can compress to 10 to 14 days.
While appeals are pending, options include paying cash with a plan for retroactive reimbursement if the appeal succeeds, using LillyDirect vials at the cash-pay rate, or starting a personalized treatment plan with compounded semaglutide through a telehealth provider during the review.
Bottom line: You have 180 days to file a level-1 internal appeal and 4 months for external review
FAQ
Can I Appeal an Anthem Zepbound Denial Without My Doctor’s Help?
Possible but rare to succeed. The Letter of Medical Necessity from the prescriber carries clinical authority that a patient-written letter cannot match. Most prescribers will write an LMN if you provide the denial letter and ask in writing.
Does Anthem Cover Zepbound for Medicare Patients?
No, in most cases. Medicare Part D does not cover Zepbound for obesity as of 2026. CMS has not extended Part D coverage to the obesity indication for tirzepatide. Some Anthem Medicare Advantage plans cover Zepbound under the OSA indication after the December 2024 approval, but this varies by plan and benefit design.
Does Anthem Require Wegovy STEP Therapy Before Zepbound?
Yes, on most plans. Anthem typically requires prior trial of Wegovy or another GLP-1 first. The step requirement can be waived with documented contraindication, intolerance, or insufficient response. A documented prior failure on Wegovy due to GI tolerability or insufficient weight loss after a full titration trial is the easiest waiver.
How Much Does Zepbound Cost with Anthem Coverage?
With PA approved on Tier 3, expect a copay of $40 to $100 per month for commercial plans. High-deductible plans charge the full negotiated rate (around $900 to $1,000) until the deductible is met. Without coverage, brand Zepbound lists at about $1,059 per month, with the LillyDirect direct-cash program running $349 to $499 per month for vials.
Can I Get an Expedited Appeal If I Have Severe OSA?
Yes. Severe OSA with documented AHI of 30 or higher, documented daytime sleepiness with motor vehicle accident risk, or evidence of cardiovascular complications all support an expedited appeal request. The prescriber must attest in writing that delay would jeopardize health.
What Documents Does CarelonRx Want in a Zepbound Appeal?
A signed appeal letter from you, a Letter of Medical Necessity from your prescriber, chart notes from the past 12 months, BMI and weight history, documentation of the 6-month weight management program, prior medication trials with dates, and (for the OSA pathway) a polysomnography report with AHI documentation.
Is There a Zepbound Savings Program Through Eli Lilly?
Yes. The Lilly Savings Card can bring eligible commercially-insured patients to as low as $25 per month for Zepbound pens for short periods. The LillyDirect direct-cash pharmacy offers Zepbound single-dose vials at $349 to $499 per month for cash-pay patients, available without insurance approval through a connected telehealth assessment.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.
Related Articles
Transforming Lives, One Step at a Time
Keep reading
How to Maintain Weight Loss After Stopping Zepbound
Stopping Zepbound is a significant decision, and the period immediately after is when the strategies you put in place matter most. The biology of…
What Happens After You Reach Your Goal Weight on Zepbound?
Reaching your goal weight on Zepbound is a significant milestone, and it raises a question that doesn’t get enough attention during the early stages…
Zepbound Withdrawal Symptoms: What to Expect Off the Drug
Zepbound does not cause physical withdrawal the way opioids or benzodiazepines do.
